Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma (Q33399706)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article
Language Label Description Also known as
English
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma
scientific article

    Statements

    title
    Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    22335534
    retrieved
    26 July 2017
    main subject
    thalidomide
    0 references
    cites work

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q33399706&oldid=1837014657"